Blue Owl Capital Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.28M | Buy |
255,238
+102,000
| +67% | +$3.71M | 3% | 10 |
|
|
2025
Q1 | $5.55M | Buy |
153,238
+35,000
| +30% | +$1.27M | 1.79% | 15 |
|
|
2024
Q4 | $4.97M | Sell |
118,238
-45,000
| -28% | -$1.89M | 1.15% | 20 |
|
|
2024
Q3 | $9.07M | Sell |
163,238
-105,000
| -39% | -$5.83M | 1.75% | 15 |
|
|
2024
Q2 | $11M | Hold |
268,238
| – | – | 3.07% | 11 |
|
|
2024
Q1 | $12.5M | Buy |
268,238
+5,000
| +2% | +$233K | 2.5% | 12 |
|
|
2023
Q4 | $12.6M | Buy |
+263,238
| New | +$12.6M | 3.01% | 11 |
|